CADEN MIDDLETON: Open Payments
NPI 1437740180 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,469 in 81 payments from 11 companies in 2025. Trend: 2023 $981 · 2024 $1,014 · 2025 $1,469
Food & beverage: $1,469
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $378 |
| ABBVIE INC. | 19 | $232 |
| Otsuka America Pharmaceutical, Inc. | 9 | $209 |
| Vanda Pharmaceuticals Inc. | 9 | $189 |
| Teva Pharmaceuticals USA, Inc. | 5 | $113 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| Lundbeck LLC | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $71 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| Alkermes, Inc. | 2 | $45 |
Products named: CAPLYTA, REXULTI, VRAYLAR, FANAPT, AUSTEDO XR, Auvelity, HETLIOZ, TRINTELLIX.
Industry payments across AR — which companies pay providers there.
